The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Climaco John M since 2013.
This trader's CIK number is 1546797.
At the time of last reporting, Climaco John M was the Chief Executive Officer of Cns Pharmaceuticals, Inc.. (stock ticker symbol CNSP).
Also see all insider trading activities at Cns Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | DRAD | 6,000 | $4,920 | 0 | $0 | 1,250 | $0 |
| 2018 | DRAD | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2017 | DRAD | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2016 | DRAD | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2013 | DRAD | 13,100 | $50,048 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CNSP | 166,666 | $49,999 | 0 | $0 | 0 | $0 |
| 2023 | CNSP | 17,750 | $15,354 | 0 | $0 | 1,250 | $0 |
1. Star Equity Holdings, Inc. (DRAD)
2. Cns Pharmaceuticals, Inc. (CNSP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-08-06 | DRAD | Option Ex | 1,250 | .00 | 0 |
| 2019-03-15 | DRAD | Buy | 6,000 | .82 | 4,920 |
| 2018-08-08 | DRAD | Option Ex | 12,500 | .00 | 0 |
| 2017-08-02 | DRAD | Option Ex | 12,500 | .00 | 0 |
| 2016-07-31 | DRAD | Option Ex | 12,500 | .00 | 0 |
| 2013-11-11 | DRAD | Buy | 3,000 | 4.23 | 12,698 |
| 2013-11-12 | DRAD | Buy | 5,000 | 4.28 | 21,395 |
| 2013-11-13 | DRAD | Buy | 1,369 | 4.37 | 5,975 |
| 2013-08-26 | DRAD | Buy | 3,731 | 2.67 | 9,980 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-01 | CNSP | Buy | 166,666 | .30 | 49,999 |
| 2023-08-16 | CNSP | Buy | 2,750 | 1.80 | 4,944 |
| 2023-04-28 | CNSP | Option Ex | 1,250 | .00 | 0 |
| 2023-04-12 | CNSP | Buy | 15,000 | .69 | 10,410 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Climaco John M (Chief Executive Officer of Cns Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.